CPRX
CATALYST PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$31.49
+0.00%Latest reported
- Last report date
- May 12, 2026
- EPS actual
- $0.74
- EPS estimate
- $0.64
- Revenue actual
- $149.3M
- Revenue estimate
- $149.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +16.2%
- Revenue beats (12Q)
- 8
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 12, 2026 | $0.64 | $0.74 | Beat 15.62% | $149.3M |
| Feb 26, 2026 | $0.42 | $0.41 | Miss -1.40% | $152.6M |
| Nov 5, 2025 | $0.51 | $0.68 | Beat 33.33% | $148.4M |
| Aug 6, 2025 | $0.58 | $0.68 | Beat 17.24% | $146.6M |
| May 7, 2025 | $0.53 | $0.68 | Beat 28.30% | $141.4M |
| Feb 26, 2025 | $0.32 | $0.70 | Beat 118.75% | $141.8M |
| Feb 28, 2024 | $0.48 | $0.53 | Beat 10.42% | $110.6M |
| Mar 15, 2023 | $0.21 | $0.22 | Beat 4.76% | $60.8M |
| Nov 9, 2022 | $0.19 | $0.20 | Beat 5.26% | $57.2M |
| Aug 9, 2022 | $0.17 | $0.20 | Beat 17.65% | $53.1M |
| Mar 16, 2022 | $0.12 | $0.09 | Miss -25.00% | $38.3M |
| Mar 15, 2021 | $0.09 | $0.11 | Beat 22.22% | $31.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 5, 2026